December 30, 2019
- FDA approves olaparib for gBRCAm metastatic pancreatic adenocarcinoma
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- National Drug Code Directory (updated)
- NDC Unfinished Drugs Excluded Database File (updated)
- NDC Database Excluded Packages and Products (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario